isocarboxazid has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Depression is common in Huntington's disease." | 1.27 | Treatment of depression in Huntington's disease with monoamine oxidase inhibitors. ( Ford, MF, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford, MF | 1 |
1 other study available for isocarboxazid and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Treatment of depression in Huntington's disease with monoamine oxidase inhibitors.
Topics: Adult; Aged; Depression; Female; Humans; Huntington Disease; Isocarboxazid; Middle Aged; Monoamine O | 1986 |